XOMA Royalty Corp
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 2200 POWELL STREET, EMERYVILLE, CA, 94608
Mailing Address 2200 POWELL STREET, EMERYVILLE, CA, 94608
Phone 510-204-7239
Fiscal Year End 1231
EIN 522154066
Financial Overview
FY2024 FY
$28.49M
Revenue
-$13.82M
Net Income
$234.30M
Total Assets
$145.58M
Total Liabilities
$153.29M
Cash & Equivalents
$-4.04
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K/A Current report amendment | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 3 Initial insider ownership report | January 14, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 4 Insider stock transaction report | December 8, 2025 | View on SEC |
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 8-K Current report of material events | November 21, 2025 | View on SEC |
Material Events
8-K Acquisition February 9, 2026
High Impact
- XOMA Royalty Corp. acquired Generation Bio Co., marking a strategic shift beyond its traditional royalty business.
- The acquisition provides XOMA with direct ownership and management of high-potential assets, including gene therapy programs and a collaboration with ModernaTX, Inc.
8-K Acquisition December 5, 2025
High Impact
- XOMA Royalty Corp completed a major acquisition of Mural Oncology plc, taking full ownership of the company and its drug development business.
- This acquisition represents a strategic shift for XOMA, moving beyond its traditional royalty collection model to direct involvement in drug development.
Insider Trading
BUY 1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.